As of today (2024-04-24), Bio-Techne's share price is $63.52.
Bio-Techne's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $1.40. Hence, Bio-Techne's Price-to-Free-Cash-Flow Ratio for today is 45.47.
The historical rank and industry rank for Bio-Techne's Price-to-Free-Cash-Flow or its related term are showing as below:
TECH'
s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 21.25 Med: 42.61 Max: 79.56
Current: 45.44
During the past 13 years, Bio-Techne's highest Price-to-Free-Cash-Flow Ratio was 79.56. The lowest was 21.25. And the median was 42.61.
TECH's Price-to-Free-Cash-Flow is ranked worse than 59.62% of 213
companies
in the Biotechnology industry
Industry Median: 31
vs TECH: 45.44
During the past 12 months, the average Free Cash Flow per Share Growth Rate of Bio-Techne was -9.60% per year.
During the past 3 years, the average Free Cash Flow per Share Growth Rate was 11.10% per year.
During the past 5 years, the average Free Cash Flow per Share Growth Rate was 11.50% per year.
During the past 10 years, the average Free Cash Flow per Share Growth Rate was 8.80% per year.
During the past 13 years, Bio-Techne's highest 3-Year average Free Cash Flow per Share Growth Rate was 129.10% per year. The lowest was -1.90% per year. And the median was 14.00% per year.
Bio-Techne Price-to-Free-Cash-Flow Historical Data
The historical data trend for Bio-Techne's Price-to-Free-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Bio-Techne's Price-to-Free-Cash-Flow
For the Biotechnology subindustry, Bio-Techne's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bio-Techne's Price-to-Free-Cash-Flow Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Bio-Techne's Price-to-Free-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Bio-Techne's Price-to-Free-Cash-Flow falls into.
Bio-Techne Price-to-Free-Cash-Flow Calculation
Bio-Techne's Price-to-Free-Cash-Flow ratio for today is calculated as
Bio-Techne's Share Price of today is $63.52.
Bio-Techne's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.40.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.
In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.
Be Aware
In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.
Bio-Techne Price-to-Free-Cash-Flow Related Terms
Thank you for viewing the detailed overview of Bio-Techne's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TECH has been successfully added to your 